Aphria Stock Price, Forecast & Analysis (NYSE:APHA)

Aphria trades on the New York Stock Exchange (NYSE) under the ticker symbol "APHA."

Aphria Inc (NYSE:APHA) posted its earnings results on Tuesday, October, 15th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.10. The firm earned $126.10 million during the quarter, compared to analyst estimates of $131.15 million. The company's quarterly revenue was up 848.1% on a year-over-year basis. View Aphria's Earnings History.

Aphria is scheduled to release their next quarterly earnings announcement on Friday, January 10th 2020. View Earnings Estimates for Aphria.

Aphria issued an update on its FY 2020 earnings guidance on Tuesday, October, 15th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $650-700 million.

9 Wall Street analysts have issued 1-year price objectives for Aphria's stock. Their forecasts range from $6.50 to $22.75. On average, they anticipate Aphria's share price to reach $12.12 in the next twelve months. This suggests a possible upside of 185.1% from the stock's current price. View Analyst Price Targets for Aphria.

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 1 sell rating, 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Aphria.

News articles about APHA stock have trended very positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Aphria earned a media sentiment score of 3.3 on InfoTrie's scale. They also gave news articles about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Aphria.

Aphria saw a increase in short interest in October. As of October 15th, there was short interest totalling 32,710,000 shares, an increase of 26.4% from the September 15th total of 25,870,000 shares. Based on an average daily trading volume, of 5,530,000 shares, the short-interest ratio is currently 5.9 days. Approximately 14.1% of the shares of the stock are sold short. View Aphria's Current Options Chain.

Some companies that are related to Aphria include Premier (PINC), Healthequity (HQY), Healthscope (HSO), BioNTech (BNTX), Spark Therapeutics (ONCE), Repligen (RGEN), bluebird bio (BLUE), Mirati Therapeutics (MRTX), LHC Group (LHCG), The Medicines (MDCO), United Therapeutics (UTHR), BTG (BTGGF), Ablynx (ABLYF), NuVasive (NUVA) and ConvaTec Group (CTEC).

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Tilray (TLRY), NVIDIA (NVDA), HEXO (HEXO), Charlotte's Web (CWBHF), KushCo (KSHB), Aurora Cannabis (ACB) and OrganiGram (OGI).

Aphria's stock is owned by many different of institutional and retail investors. Top institutional investors include CIBC Asset Management Inc (0.06%), Creative Planning (0.03%), Commerzbank Aktiengesellschaft FI (0.03%), Exane Derivatives (0.02%), Cambridge Investment Research Advisors Inc. (0.01%) and Great West Life Assurance Co. Can (0.01%).

APHA stock was sold by a variety of institutional investors in the last quarter, including Exane Derivatives, Great West Life Assurance Co. Can and AE Wealth Management LLC.

APHA stock was bought by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Cambridge Investment Research Advisors Inc., CIBC Asset Management Inc, Signition LP, First Allied Advisory Services Inc., Wedbush Securities Inc., Sfmg LLC and Creative Planning.

Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of APHA stock can currently be purchased for approximately $4.25.

Aphria has a market capitalization of $1.07 billion and generates $179.29 million in revenue each year. Aphria employs 300 workers across the globe.View Additional Information About Aphria.